Design, synthesis and evaluation of coumarin-pargyline hybrids as novel dual inhibitors of monoamine oxidases and amyloid-β aggregation for the treatment of Alzheimer's disease

被引：49

作者：

Yang, Hua-Li ^{[1
,2
,3
]}

Cai, Pei ^{[2
,3
]}

Liu, Qiao-Hong ^{[2
,3
]}

Yang, Xue-Lian ^{[2
,3
]}

Li, Fan ^{[2
,3
]}

Wang, Jin ^{[2
,3
]}

Wu, Jia-Jia ^{[2
,3
]}

Wang, Xiao-Bing ^{[2
,3
]}

Kong, Ling-Yi ^{[1
,2
,3
]}

机构：

[1] Shenyang Pharmaceut Univ, Sch Tradit Chinese Mat Med, Shenyang 110016, Liaoning, Peoples R China

[2] China Pharmaceut Univ, Jiangsu Key Lab Bioact Nat Product Res, Nanjing 210009, Jiangsu, Peoples R China

[3] China Pharmaceut Univ, State Key Lab Nat Med, Dept Nat Med Chem, Nanjing 210009, Jiangsu, Peoples R China

来源：

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2017年 / 138卷

关键词：

Alzheimer's disease; Coumarin; Pargyline; Monoamine oxidases; A beta(1-42) aggregation; MULTITARGET-DIRECTED LIGANDS; BIOLOGICAL EVALUATION; ACETYLCHOLINESTERASE INHIBITORS; METAL CHELATION; B INHIBITION; DERIVATIVES; CHOLINESTERASE; ANTIOXIDANT; TARGET; POTENT;

D O I：

10.1016/j.ejmech.2017.07.008

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of coumarin-pargyline hybrids (4a-x) have been designed, synthesized and evaluated as novel dual inhibitors of Alzheimer's disease (AD). Most of the compounds exhibited a potent ability to inhibit amyloid-beta (A(beta) aggregation and monoamine oxidases. In particular, compound 4x exhibited remarkable inhibitory activities against monoamine oxidases (IC50, 0.027 +/- 0.004 AM for MAO-B; 3.275 +/- 0.040 mu M for MAO-A) and A beta(1-42) aggregation (54.0 +/- 1.1%, 25 mu M). Moreover, compound 4x showed low toxicity according to in vitro cell toxicity test. The results of the parallel artificial membrane permeability assay for blood-brain barrier indicated that compound 4x would be potent to cross the blood-brain barrier. Collectively, these findings demonstrate that compound 4x was an effective and promising candidate for AD therapy. (C) 2017 Elsevier Masson SAS. All rights reserved.

引用

页码：715 / 728

页数：14

共 50 条

[41] A novel series of tacrine-selegiline hybrids with cholinesterase and monoamine oxidase inhibition activities for the treatment of Alzheimer's disease [J].

Lu, Chuanjun ;

Zhou, Qi ;

Yan, Jun ;

Du, Zhiyun ;

Huang, Ling ;

Li, Xingshu .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 62 :745-753

[42] Design, synthesis and biological evaluation of novel coumarin derivatives as multifunctional ligands for the treatment of Alzheimer's disease [J].

Liu, Wenjie ;

Wu, Limeng ;

Liu, Wenwu ;

Tian, Liting ;

Chen, Huanhua ;

Wu, Zhongchan ;

Wang, Nan ;

Liu, Xin ;

Qiu, Jingsong ;

Feng, Xiangling ;

Xu, Zihua ;

Jiang, Xiaowen ;

Zhao, Qingchun .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 242

[43] Assessment of Novel Curcumin Derivatives as Potent Inhibitors of Inflammation and Amyloid-β Aggregation in Alzheimer's Disease [J].

Lakey-Beitia, Johant ;

Gonzalez, Yisett ;

Doens, Deborah ;

Stephens, David E. ;

Santamaria, Ricardo ;

Murillo, Enrique ;

Gutierrez, Marcelino ;

Fernandez, Patricia L. ;

Rao, K. S. ;

Larionov, Oleg V. ;

Durant-Archibold, Armando A. .

JOURNAL OF ALZHEIMERS DISEASE, 2017, 60 :S59-S68

[44] Benzimidazole-derived carbohydrazones as dual monoamine oxidases and acetylcholinesterase inhibitors: design, synthesis, and evaluation [J].

Kumar, Sandeep ;

Jaiswal, Shivani ;

Gupta, Sukesh Kumar ;

Ayyannan, Senthil Raja .

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2024, 42 (09) :4710-4729

[45] Design, synthesis, and biological evaluation of novel capsaicin-tacrine hybrids as multi-target agents for the treatment of Alzheimer's disease [J].

Long, Juanyue ;

Qin, Fengxue ;

Luo, Jinchong ;

Zhong, Guohui ;

Huang, Shutong ;

Jing, Lin ;

Yi, Tingzhuang ;

Liu, Jing ;

Jiang, Neng .

BIOORGANIC CHEMISTRY, 2024, 143

[46] Design, synthesis and evaluation of novel feruloyl-donepezil hybrids as potential multitarget drugs for the treatment of Alzheimer's disease [J].

Dias, Kris Simone T. ;

de Paula, Cynthia T. ;

dos Santos, Thiago ;

Souza, Isis N. O. ;

Boni, Marina S. ;

Guimaraes, Marcos J. R. ;

da Silva, Fernanda M. R. ;

Castro, Newton G. ;

Neves, Gilda A. ;

Veloso, Clarice C. ;

Coelho, Marcio M. ;

de Melo, Ivo Souza F. ;

Giusti, Fabiana C. V. ;

Giusti-Paiva, Alexandre ;

da Silva, Marcelo L. ;

Dardenne, Laurent E. ;

Guedes, Isabella A. ;

Pruccoli, Letizia ;

Morroni, Fabiana ;

Tarozzi, Andrea ;

Viegas, Claudio, Jr. .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 130 :440-457

[47] Synthesis and pharmacological evaluation of donepezil-based agents as new cholinesterase/monoamine oxidase inhibitors for the potential application against Alzheimer's disease [J].

Li, Fan ;

Wang, Zhi-Min ;

Wu, Jia-Jia ;

Wang, Jin ;

Xie, Sai-Sai ;

Lan, Jin-Shuai ;

Xu, Wei ;

Kong, Ling-Yi ;

Wang, Xiao-Bing .

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2016, 31 :41-53

[48] Dual inhibitors of Interleukin-6 and acetylcholinesterase for treatment of Alzheimer's disease: Design, docking, synthesis and biological evaluation [J].

Kaur, Sukhvir ;

Bansal, Yogita .

JOURNAL OF THE INDIAN CHEMICAL SOCIETY, 2021, 98 (10)

[49] A comprehensive review on synthesis and designing aspects of coumarin derivatives as monoamine oxidase inhibitors for depression and Alzheimer's disease [J].

Patil, Pravin O. ;

Bari, Sanjay B. ;

Firke, Sandip D. ;

Deshmukh, Prashant K. ;

Donda, Shailesh T. ;

Patil, Dilip A. .

BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (09) :2434-2450

[50] Novel inhibitors of AChE and A0 aggregation with neuroprotective properties as lead compounds for the treatment of Alzheimer's disease [J].

Liu, Yulin ;

Uras, Giuseppe ;

Onuwaje, Itse ;

Li, Wenlong ;

Yao, Hong ;

Xu, Shengtao ;

Li, Xinuo ;

Li, Xinnan ;

Phillips, James ;

Allen, Stephanie ;

Gong, Qi ;

Zhang, Haiyan ;

Zhu, Zheying ;

Liu, Jie ;

Xu, Jinyi .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 235

← 1 2 3 4 5 →